
Sign up to save your podcasts
Or


Fibrosis associated with chronic pancreatitis is an irreversible lesion that can disrupt pancreatic exocrine and endocrine function. Currently, there are no approved treatments for this disease.
In this podcast Mairi McLean, Gut education editor, talks to Professor Yoshiro Niitsu from Sapporo Medical University School of Medicine about his manuscript about the potential for therapeutic use of siRNA in the treatment of pancreatic fibrosis.
Read the full research online:
http://gut.bmj.com/content/62/9/1328
By BMJ Group4.1
77 ratings
Fibrosis associated with chronic pancreatitis is an irreversible lesion that can disrupt pancreatic exocrine and endocrine function. Currently, there are no approved treatments for this disease.
In this podcast Mairi McLean, Gut education editor, talks to Professor Yoshiro Niitsu from Sapporo Medical University School of Medicine about his manuscript about the potential for therapeutic use of siRNA in the treatment of pancreatic fibrosis.
Read the full research online:
http://gut.bmj.com/content/62/9/1328

136 Listeners

318 Listeners

498 Listeners

37 Listeners

48 Listeners

68 Listeners

4 Listeners

5 Listeners

3 Listeners

1 Listeners

3 Listeners

10 Listeners

40 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

31 Listeners

17 Listeners

3 Listeners

3,341 Listeners

3 Listeners

20 Listeners

1,149 Listeners

193 Listeners

512 Listeners

23 Listeners

367 Listeners

247 Listeners

370 Listeners

17 Listeners

0 Listeners